ABOUT CONOLIDINE

Inside of a the latest review, we claimed the identification and the characterization of a completely new atypical opioid receptor with exceptional adverse regulatory properties to opioid peptides.1 Our success showed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is usually a wide-spectru